Sources: *Data on file ** Singer AJ, et al. Comparison of wound-bursting strengths and surface characteristics of FDA-approved tissue adhesive for skin closure. J Adhes Sci Technol. 2004; 18:10-27 †Data on file: Exofin® was tested in vitro to demonstrate that it acts as a barrier to clinically relevant organisms including Methicillin Resistant S. aureus (MRSA), E. coli, P. aeruginosa, S. epidermidis and Aspergillus brasliensis.